Dare Bioscience, Inc.
DARE· Nasdaq
DAREDare Bioscience, Inc.
Filed May 12, 2022 · 10-Q · 42 days after period end · 0001401914-22-000051
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Net Income | -$8.40M | -$7.32M | -$4.25M | -$3.05M |
| EPS Diluted | -$0.10 | -$0.16 | -$0.18 | -$0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 12, 2022 · 42 d after period end
